Merck Immune For 'Inflated' Vax Claims To FDA, 3rd Circ. Says

By Bryan Koenig · October 7, 2024, 8:56 PM EDT

A divided Third Circuit panel inoculated Merck from claims that it tried to prevent competition by making inflated declarations to federal regulators about its mumps vaccine, with the majority ruling Monday...

To view the full article, register now.

Documents

Case Information

Case Title

In re: Merck Mumps Vaccine Antitrust Litigation

Case Number

23-3089

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

November 27, 2023